Who
Allen Nissenson
Director
Company insider
Files Form 4 as: Director, Elicio Therapeutics; Director, Rockwell Medical; Chief Medical Officer, DaVita.
In numbers
- Trades disclosed
- 98
- Buys
- 2
- Sells
- 12
- Bought
- $11K
- Sold
- $2.8M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 1 Aug 2008
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,750 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,750 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —9,633 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —9,633 at $0.00 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 May 2025filed 20 May 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,900 at $0.00 | filing |
| 21 Nov 2024filed 25 Nov 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,100 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —36,111 at $0.00 | filing |
| 28 Dec 2023filed 29 Dec 2023 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,100 at $0.00 | filing |
| 23 May 2023filed 25 May 2023 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —24,715 at $0.00 | filing |
| 9 Jun 2022filed 13 Jun 2022 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 May 2022filed 23 May 2022 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Bought | $2,4042,037 at $1.18 | filing |
| 19 May 2022filed 23 May 2022 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Bought | $8,5217,346 at $1.16 | filing |
| 17 Jun 2021filed 22 Jun 2021 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —72,857 at $0.00 | filing |
| 17 Jun 2021filed 22 Jun 2021 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Mar 2021filed 10 Mar 2021 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 11 Dec 2020filed 15 Dec 2020 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —1,488 at $0.00 | filing |
| 11 Jun 2020filed 12 Jun 2020 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —34,639 at $0.00 | filing |
| 11 Jun 2020filed 12 Jun 2020 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
News
7,152 Shares of DaVita Inc. $DVA Purchased by Westwind CapitalDVA · dailypolitical.com · 9 Oct 2026
0 headlines in the last 90 days name Allen Nissenson; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.